Posted by keyman > 2024-03-07 22:11 | Report Abuse

今天taurx announce 的information. 之前在Agm的时候就mention过了。害我还以为会有什么特别的info. 弄的紧张兮兮的。看各位师父还气定神闲，像没什么一样，就知道我和各位师父们的差距。让你们见笑了🤭未来还请师父们多多指点我。谢谢各位师父🙏

Posted by Pyh96 > 2024-03-07 22:16 | Report Abuse

Thats old news

Posted by newbie2019 > 2024-03-07 22:16 | Report Abuse

Anyone can help to explain this result? Or tomorrow should be up or down? Big time?

Posted by Pyh96 > 2024-03-07 22:17 | Report Abuse

Please verify and dont just copy and paste from other platform to misguide the others LOL

Posted by Michael_chan2022 > 2024-03-07 22:18 | Report Abuse

Back to basics.. focus on its core businesses 💪

Posted by Ytl2023 > 2024-03-07 22:36 | Report Abuse

Aiyo drop also back to rm4.60- rm4.70. Later back to Rm5. Every year also same trend

Posted by rohank71 > 2024-03-07 22:44 | Report Abuse

wait for tomorrow morning.

Posted by FIREBull > 2024-03-07 22:57 | Report Abuse

The TauRx result is out. Tomorrow GENTING fly.

https://taurx.com/news-insights/two-year-sustained-cognitive-benefits-of-hydromethylthionine-mesylate-hmtm-indicated-by-taurxs-lucidity-trial

Posted by mikewazowski > 2024-03-07 22:58 | Report Abuse

, showed significantly REDUCED disease progression in participants in the LUCIDITY trial. - FROM THE REPORT

Posted by Investor101 > 2024-03-07 23:00 | Report Abuse

https://taurx.com/news-insights/two-year-sustained-cognitive-benefits-of-hydromethylthionine-mesylate-hmtm-indicated-by-taurxs-lucidity-trial

the most positive data and news ever in AD!

Posted by Mtrade > 2024-03-07 23:06 | Report Abuse

I think tmr GENTING can open above RM5… VERY good news from Taurx published result

Posted by Mtrade > 2024-03-07 23:06 | Report Abuse

As maybank said potentially the value is RM9, Taurx is promising

Posted by choysun > 2024-03-07 23:32 | Report Abuse

Next dilemma people will face, when to sell... :p

Posted by rohank71 > 2024-03-08 00:19 | Report Abuse

Next short term resistance 4.91 and 5.20.... Long term is resistance 5.20 and then 6.50. in between minor speedbreaks at 5.80.

Posted by Save > 2024-03-08 00:42 | Report Abuse

Drug development is never been easy. Reaching Phase 3 is never easy.
 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210334/
Thirty‐seven new therapies—22 new chemical entities and 15 biologics—were approved by the FDA in 2022 across all therapeutic categories. 9 Five agents are active in the central nervous system (CNS) including one agent for relapsing multiple sclerosis, one treatment for amyotrophic lateral sclerosis, one anticonvulsant, and one therapy for the treatment of insomnia. One biological agent was directed at cerebral adrenoleukodystrophy to slow the progression of neurologic dysfunction. This is the smallest number of new drugs approved since 2016. There were no new treatments approved for AD in 2022. In 2021 and 2023, respectively, aducanumab and lecanemab received accelerated approval for the treatment of AD. Development for AD continues to be challenging with only these two drugs approved since 2003.

Posted by hiroshi03 > 2024-03-08 00:58 | Report Abuse

Prof. Wischik's work on Tau pathology began in 1985 in the laboratory of Sir Martin Roth, who was the first to correlate tangles with Alzheimer's dementia, and later with Sir Aaron Klug (Nobel Laureate) at Cambridge University.

Posted by kokchengkai > 2024-03-08 05:06 | Report Abuse

Newbie2019 result as expected is positive . see when can get approval to sell in msrket then only talk abt genting share rocket up

Posted by Jack Khan > 2024-03-08 05:23 | Report Abuse

For Genting to go up we need to wait for
1. FDA approval
2. Taurx planed list in Nasdaq with valuation of USD 15b
for now fair value will be rm5 - 5.90
If FDA approves then may fly to 6-7!
if listed in Nasdaq may fly between 6-9 depend on the valuation!

Posted by Jack Khan > 2024-03-08 05:29 | Report Abuse

So far Current treatments help improve Alzheimer's symptoms, but no drug has yet been shown to slow disease progression. Lucidity is first drug that slow the AD progression!

Posted by birkincollector > 2024-03-08 05:59 | Report Abuse

dont just think about how much you earn, think about the how this drug will help millions of people around the world

Posted by Riaz1954 > 2024-03-08 06:36 | Report Abuse

Once approval is given or even just before some big pharma company may make an offer to JV or similar to manufacture market and distribute the product. What ever happens 2024 promises to be an exciting year. Remember markets look ahead. Those who sell early may miss out on ultimate gains.

Posted by Riaz1954 > 2024-03-08 06:52 | Report Abuse

Panel discussion today will further cement the outcome and success of the drug. New investors will pile in perhaps foreign flows when market opens later this afternoon. It will take time for news to filter through and ultimate possibilities will run for while. With 1qtr showing uptick things will look better.

Posted by Riaz1954 > 2024-03-08 06:53 | Report Abuse

Jack Khan fair value before Taurx was 5.70!

Posted by hiroshi03 > 2024-03-08 07:40 | Report Abuse

https://www.nst.com.my/amp/business/2022/06/804468/genting-set-early-monetisation-associate-firm-taurx

Posted by Lpkoh > 2024-03-08 07:56 | Report Abuse

LU this morning very likely

Posted by Michael_chan2022 > 2024-03-08 08:15 | Report Abuse

保持...平常心

Posted by Michael_chan2022 > 2024-03-08 08:20 | Report Abuse

Traders and shortists kena squeezed jialat.. jialat past few days. Another short squeeze today?

Posted by Michael_chan2022 > 2024-03-08 08:21 | Report Abuse

GenB是有投资升值潜力的...需要耐心。很多投资者被trader 一吓...下探4.50，全卖了……可惜啊

Posted by newbie2019 > 2024-03-08 08:27 | Report Abuse

5.4 sell 5%

Posted by Michael_chan2022 > 2024-03-08 08:30 | Report Abuse

買的便宜，才能抱的紧

Posted by Goldgent > 2024-03-08 08:32 | Report Abuse

Positive sign, average 4.98 (8.30am)

Posted by neohts > 2024-03-08 08:36 | Report Abuse

https://www.nst.com.my/amp/business/2022/06/804468/genting-set-early-monetisation-associate-firm-taurx

RHB Research said TauRx could contribute RM1.3 billion-RM4.3 billion to Genting's financial year 2024 (FY24)-FY26 earnings, assuming a 10 per cent net margin.

KUALA LUMPUR: Merger and acquisition (M&A) of Genting Bhd's 20.3 per cent-owned research and development (R&D) associate TauRx Pharmaceuticals Ltd could allow for faster monetisation versus initial public offering (IPO), RHB Research said.
The firm said while Genting did not comment on its strategy with regards to its TauRx stake, any option of value realisation or monetisation was definitely a positive after having invested in the firm since November 2012.
"For TauRx to IPO, it would need to first commercialise its lead investigative oral drug, HMTM, in 2023 and undertake listing in 2024 or later.

"Conversely, we think M&A or in-licensing agreements may allow for earlier monetisation of Genting's stake, given that large pharmaceutical firms may have M&A interest in TauRx in order to possess the world's only effective Alzheimer's treatment.

"As a plus, M&A could allow TauRx to leverage on such firms' resources to expedite HMTM speed to market," it said in a note today. RHB Research said the HMTM drug would need to undergo 12 months of open-label trials – it could seek regulatory approvals for this Alzheimer's drug before the trial's conclusion.

RHB Research said TauRx could contribute RM1.3 billion-RM4.3 billion to Genting's financial year 2024 (FY24)-FY26 earnings, assuming a 10 per cent net margin.
It could also fetch an upside of RM3.47-RM13.88 a share share based on 10x price to earnings ratio (P/E) on our base and bull cases for FY24 earnings," it said.

RHB said this could translates to hypothetical target price of RM9.84-RM20.25 for Genting.

Posted by Goldgent > 2024-03-08 08:46 | Report Abuse

Quoted 4.97 (8.45am), still positive.
Blue chip, a bit slow.

Posted by choysun > 2024-03-08 08:59 | Report Abuse

Can hear the anxious heartbeat of forumers :p

Posted by Goldgent > 2024-03-08 09:06 | Report Abuse

Back to normal in 5 minutes, FLAT.
New comrades, welcome to G counter.

Posted by DestinyL > 2024-03-08 09:16 | Report Abuse

Many stay on sideline for fear of sell on news lol

Posted by DestinyL > 2024-03-08 09:19 | Report Abuse

That's actually for the better

Posted by StartOfTheBull > 2024-03-08 09:25 | Report Abuse

Currently is there any drug for AD more effective than TauRx?

Posted by Jack Khan > 2024-03-08 09:32 | Report Abuse

Currently there is no drug for treatment that slow the progress of AD!

Posted by Jack Khan > 2024-03-08 09:43 | Report Abuse

It is lifetime medicine, each day 2-3 pills.

Posted by Riaz1954 > 2024-03-08 09:46 | Report Abuse

Genting investors had been bitten too many times and are shy ow when it matters….2024 will be defining year unless boss unloads to invest in mars. I wonder what the price trend is with Taurx share price

Posted by Jack Khan > 2024-03-08 09:48 | Report Abuse

Taurx is currently a private company, right?

Posted by DestinyL > 2024-03-08 09:49 | Report Abuse

Seems like traders are not keen on the idea of actually waiting for Taurx to bear fruit and contribute in actual QR dollars
Probably only true investors are buying in

Posted by Riaz1954 > 2024-03-08 09:55 | Report Abuse

JK…yes Taurx, is a private company. The real action and potential will be reflected in share price of TauRX

Posted by sonyx123 > 2024-03-08 10:02 | Report Abuse

https://theedgemalaysia.com/node/703916

Posted by Save > 2024-03-08 10:04 | Report Abuse

Today share price no bad, it let those purchase on 6 of March - 5.02 -4.82 (average transection price 4.90) to exit if they don't want to hold...........

Posted by neohts > 2024-03-08 10:08 | Report Abuse

https://theedgemalaysia.com/node/703916

KUALA LUMPUR (March 8): TauRx Pharmaceuticals Ltd, the 20%-owned associate of Genting Bhd, said new data show that its trial drug to combat Alzheimer's disease has “sustained benefits” across the disease spectrum from early to moderate dementia.

The new 24-month data from the third phase of the so-called LUCIDITY trial of hydromethylthionine mesylate (HMTM) showed “significantly” reduced disease progression in participants, TauRx said in a statement following a presentation at a conference in Portugal.

Genting’s target price could be raised to as high as RM9.40 under a blue sky scenario, where HMTM is approved and TauRx is valued at US$15 billion (RM70.3 billion) without discount, Maybank said.

Posted by BursaKakis > 2024-03-08 10:15 | Report Abuse

Genting's 20%-owned TauRx says new data on Alzheimer's drug show sustained benefits
https://theedgemalaysia.com/node/703916

Posted by TiffanixLVxHermes > 2024-03-08 10:25 | Report Abuse

today will break and re-test 5
next week all the way into the green green sky

Posted by Goldgent > 2024-03-08 10:27 | Report Abuse

Challenging 4.97!